home / stock / srtoy / srtoy short
Short Information | Sartorius Stedim Biotech S.A. - ADR (OTCMKTS:SRTOY)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 4,953 |
Total Actual Volume | 9,764 |
Short Trends | |
---|---|
Cover Days | 11 |
Short Days | 5 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 248 |
Average Short Percentage | 33.12% |
Is there a SRTOY Short Squeeze or Breakout about to happen?
See the SRTOY Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-15-2024 | $24.15 | $24.15 | $24.15 | $24.15 | 336 | 258 | 76.79% |
05-06-2024 | $0 | $22.655 | $0 | $0 | 15 | 1 | 6.67% |
04-30-2024 | $0 | $23.6452 | $0 | $0 | 32 | 1 | 3.12% |
04-29-2024 | $22.94 | $23.6452 | $23.6452 | $22.94 | 289 | 134 | 46.37% |
04-26-2024 | $0 | $22.93 | $0 | $0 | 36 | 1 | 2.78% |
04-23-2024 | $22.75 | $22.28 | $22.75 | $22.28 | 1,263 | 123 | 9.74% |
04-22-2024 | $21.86 | $21.3 | $21.86 | $21.215 | 2,126 | 2,030 | 95.48% |
04-19-2024 | $21.34 | $21.42 | $21.42 | $21.34 | 836 | 279 | 33.37% |
04-18-2024 | $22.4 | $22.655 | $22.66 | $22.4 | 999 | 693 | 69.37% |
04-16-2024 | $0 | $28.2 | $0 | $0 | 92 | 55 | 59.78% |
04-10-2024 | $27.495 | $27.495 | $27.495 | $27.495 | 340 | 68 | 20% |
04-09-2024 | $0 | $27.525 | $0 | $0 | 111 | 1 | 0.9% |
04-08-2024 | $0 | $27.525 | $0 | $0 | 93 | 41 | 44.09% |
04-05-2024 | $27.5 | $27.525 | $27.525 | $27.5 | 435 | 106 | 24.37% |
04-04-2024 | $27 | $27 | $27 | $27 | 277 | 2 | 0.72% |
04-03-2024 | $29.5 | $29.5 | $29.5 | $29.5 | 672 | 560 | 83.33% |
04-02-2024 | $28.275 | $28.275 | $28.275 | $28.275 | 175 | 1 | 0.57% |
04-01-2024 | $28.72 | $29.48 | $29.48 | $28.72 | 838 | 388 | 46.3% |
03-28-2024 | $28.9 | $28.955 | $28.955 | $28.9 | 554 | 209 | 37.73% |
03-27-2024 | $28.81 | $28.81 | $28.81 | $28.81 | 245 | 2 | 0.82% |
News, Short Squeeze, Breakout and More Instantly...
Sartorius Stedim Biotech S.A. - ADR Company Name:
SRTOY Stock Symbol:
OTCMKTS Market:
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions PR Newswire UK-based Albumedix Ltd. is a leader in the field of recombinant albumin-based solutions and a highly innovative and profitable company Re...